User contributions
Jump to navigation
Jump to search
- 23:11, 22 April 2024 diff hist +6 m Multiple myeloma - historical
- 23:10, 22 April 2024 diff hist +7 m Multiple myeloma - historical →Subsequent treatment
- 23:06, 22 April 2024 diff hist +1,516 N Nogapendekin alfa inbakicept (Anktiva) Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa NCI Drug Dictionary]: A fusion protein complex composed of..." current
- 23:00, 22 April 2024 diff hist +74 m Drug index →N
- 13:14, 22 April 2024 diff hist +14 m Breast cancer, ER-positive →Adjuvant therapy, premenopausal
- 13:13, 22 April 2024 diff hist +2,251 m Breast cancer, ER-positive →Goserelin & Tamoxifen {{#subobject:23ef1e|Regimen=1}}
- 13:13, 22 April 2024 diff hist +12 m Breast cancer, ER-positive
- 13:12, 22 April 2024 diff hist +2,256 Breast cancer, ER-positive →Adjuvant therapy, premenopausal
- 13:09, 22 April 2024 diff hist +2,763 m Breast cancer, ER-positive →Anastrozole monotherapy {{#subobject:a052f4|Regimen=1}}
- 13:05, 22 April 2024 diff hist +2 m Breast cancer, ER-positive
- 13:05, 22 April 2024 diff hist +2,760 Breast cancer, ER-positive →Letrozole monotherapy {{#subobject:55e6f9|Regimen=1}}
- 12:52, 22 April 2024 diff hist +630 m Chronic myeloid leukemia →Imatinib monotherapy {{#subobject:917a16|Regimen=1}} current
- 16:46, 21 April 2024 diff hist +6 m Ewing sarcoma current
- 16:42, 21 April 2024 diff hist +7 m Esophageal cancer →Subsequent treatment current
- 16:40, 21 April 2024 diff hist +7 m Diffuse large B-cell lymphoma →Subsequent treatment current
- 16:38, 21 April 2024 diff hist +96 m Classical Hodgkin lymphoma
- 16:34, 21 April 2024 diff hist +7 m Breast cancer →Subsequent treatment
- 16:33, 21 April 2024 diff hist +7 m Breast cancer →Subsequent treatment
- 12:52, 21 April 2024 diff hist +7 m Breast cancer, ER-positive →Preceding treatment
- 12:48, 21 April 2024 diff hist +12 m Breast cancer - historical
- 12:46, 21 April 2024 diff hist -51 m Acute promyelocytic leukemia current
- 12:42, 21 April 2024 diff hist +12 m Acute myeloid leukemia - historical →DAT {{#subobject:fc4f58|Regimen=1}} current
- 20:15, 20 April 2024 diff hist +2,200 m Non-small cell lung cancer →Carboplatin & Docetaxel {{#subobject:bdce59|Regimen=1}}
- 20:06, 20 April 2024 diff hist +1,560 m Breast cancer - historical →STAMP-I {{#subobject:c08ab4|Regimen=1}}
- 20:05, 20 April 2024 diff hist -1,561 m Breast cancer - historical →VAP {{#subobject:4b99b8|Regimen=1}}
- 20:04, 20 April 2024 diff hist +513 m Breast cancer - historical →CTCb, then auto HSCT {{#subobject:02f569|Regimen=1}}
- 19:55, 20 April 2024 diff hist +2,042 m Breast cancer - historical →CHUT, then auto HSCT {{#subobject:e9e363|Regimen=1}}
- 19:55, 20 April 2024 diff hist -2,042 m Breast cancer - historical →CTCb, then auto HSCT {{#subobject:02f569|Regimen=1}}
- 19:54, 20 April 2024 diff hist +2,013 m Breast cancer - historical →CHUT, then auto HSCT {{#subobject:e9e363|Regimen=1}}
- 19:53, 20 April 2024 diff hist +1,366 m Breast cancer - historical →Mitoxantrone & Vinorelbine (MV) {{#subobject:eb48ba|Regimen=1}}
- 19:50, 20 April 2024 diff hist -2,555 m Breast cancer - historical →STAMP-I {{#subobject:c08ab4|Regimen=1}}
- 19:47, 20 April 2024 diff hist +61 m Breast cancer - historical →Metastatic disease, first-line therapy
- 18:32, 20 April 2024 diff hist +118 m Acute myeloid leukemia →Upfront induction therapy, standard and older "fit" patients
- 12:56, 20 April 2024 diff hist +44 m Esophageal cancer →References
- 12:54, 20 April 2024 diff hist +68 m Esophageal cancer
- 00:40, 20 April 2024 diff hist -140 m Cutaneous squamous cell carcinoma current
- 00:39, 20 April 2024 diff hist +69 m Classical Hodgkin lymphoma
- 00:37, 20 April 2024 diff hist +845 m Classical Hodgkin lymphoma
- 00:37, 20 April 2024 diff hist -7 m Autologous HSCT →References current
- 00:36, 20 April 2024 diff hist +63 m Autologous HSCT →Regimen {{#subobject:81ff2e|Variant=1}}
- 00:22, 20 April 2024 diff hist +35 m Head and neck cancer
- 00:20, 20 April 2024 diff hist +186 m Colorectal cancer current
- 00:17, 20 April 2024 diff hist +251 m Non-small cell lung cancer
- 00:11, 20 April 2024 diff hist +69 m Malignant solid neoplasm, ERBB2-mutated →Trastuzumab emtansine monotherapy {{#subobject:0a0a41|Regimen=1}} current
- 00:10, 20 April 2024 diff hist +67 m Malignant solid neoplasm, ERBB2-mutated →Neratinib monotherapy {{#subobject:3c1a9c|Regimen=1}}
- 00:09, 20 April 2024 diff hist +1,507 Malignant solid neoplasm, ERBB2-mutated →Trastuzumab emtansine monotherapy {{#subobject:0a0a41|Regimen=1}}
- 00:03, 20 April 2024 diff hist +453 m Trastuzumab deruxtecan (Enhertu) current
- 23:55, 19 April 2024 diff hist 0 m Urothelial carcinoma
- 23:50, 19 April 2024 diff hist +3 m Melanoma →Regimen variant #1, 2 mg/kg q3wk {{#subobject:25a9fe|Variant=1}} current
- 23:49, 19 April 2024 diff hist +3 m Melanoma →Regimen variant #2, indefinite {{#subobject:722e51|Variant=1}}